GSK-3α/β and MEK Inhibitors Assist the Microenvironment of Tumor Initiation

Human iPSCs reprogrammed from monocytes of healthy volunteers were cultured in a media containing 50% of the conditioned medium from human pancreatic cancer derived BxPC3 cells supplemented with a MEK inhibitor and a GSK-3α/β inhibitor.